120 related articles for article (PubMed ID: 17585308)
1. Predictive value of the efficacy of glaucoma medications in regulatory trials: Phase I-III to post-marketing studies.
Stewart WC; Jenkins JN
Eye (Lond); 2008 Aug; 22(8):985-8. PubMed ID: 17585308
[TBL] [Abstract][Full Text] [Related]
2. Intraocular pressure efficacy of glaucoma medications versus placebo in phase II compared to later phase trials.
Sharpe RA; Nelson LA; Stewart JA; Stewart WC
Br J Ophthalmol; 2013 Feb; 97(2):121-5. PubMed ID: 23060621
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.
Katz LJ; Simmons ST; Craven ER
Curr Med Res Opin; 2007 Dec; 23(12):2971-83. PubMed ID: 17949534
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
5. The placebo effect in early-phase glaucoma clinical trials.
Sharpe RA; Nelson LA; Stewart JA; Stewart WC
Curr Eye Res; 2015 May; 40(6):653-6. PubMed ID: 25117918
[TBL] [Abstract][Full Text] [Related]
6. Average versus highest intraocular pressure analyses in glaucoma clinical trials.
DeMill DL; Wirostko BM; Nelson LA; Stewart JA; Stewart WC
Ophthalmic Res; 2013; 49(1):49-51. PubMed ID: 23128328
[TBL] [Abstract][Full Text] [Related]
7. The effect of travoprost on daytime intraocular pressure in normal tension glaucoma: a randomised controlled trial.
Ang GS; Kersey JP; Shepstone L; Broadway DC
Br J Ophthalmol; 2008 Aug; 92(8):1129-33. PubMed ID: 18511540
[TBL] [Abstract][Full Text] [Related]
8. Ocular hypotensive medications for the treatment of glaucoma.
Lee DA
Ophthalmol Clin North Am; 2005 Dec; 18(4):529-38. PubMed ID: 16314217
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
Williams RD; Cohen JS; Gross RL; Liu CC; Safyan E; Batoosingh AL;
Br J Ophthalmol; 2008 Oct; 92(10):1387-92. PubMed ID: 18621791
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of the efficacy of glaucoma medications in animal models: preclinical to regulatory studies.
Stewart WC; Magrath GN; Demos CM; Nelson LA; Stewart JA
Br J Ophthalmol; 2011 Oct; 95(10):1355-60. PubMed ID: 21169272
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma.
Quaranta L; Pizzolante T; Riva I; Haidich AB; Konstas AG; Stewart WC
Br J Ophthalmol; 2008 Sep; 92(9):1227-31. PubMed ID: 18586898
[TBL] [Abstract][Full Text] [Related]
12. Intermediate-term outcome and success of superior versus inferior Ahmed Glaucoma Valve implantation.
Rachmiel R; Trope GE; Buys YM; Flanagan JG; Chipman ML
J Glaucoma; 2008; 17(7):584-90. PubMed ID: 18854738
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.
Aptel F; Cucherat M; Denis P
J Glaucoma; 2008 Dec; 17(8):667-73. PubMed ID: 19092464
[TBL] [Abstract][Full Text] [Related]
14. Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials.
Varma R; Hwang LJ; Grunden JW; Bean GW
Am J Ophthalmol; 2008 Feb; 145(2):336-42. PubMed ID: 18222194
[TBL] [Abstract][Full Text] [Related]
15. Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range.
Varma R; Hwang LJ; Grunden JW; Bean GW; Sultan MB
Am J Ophthalmol; 2009 Aug; 148(2):221-6. PubMed ID: 19427617
[TBL] [Abstract][Full Text] [Related]
16. Effects of central corneal thickness on the efficacy of topical ocular hypotensive medications.
Johnson TV; Toris CB; Fan S; Camras CB
J Glaucoma; 2008 Mar; 17(2):89-99. PubMed ID: 18344753
[TBL] [Abstract][Full Text] [Related]
17. Techniques to Reduce the Placebo Effect in Glaucoma Clinical Trials.
Sharpe RA; Davidson J; Nelson LA; Stewart JA; Stewart WC
Ophthalmic Res; 2015; 54(1):3-5. PubMed ID: 25969364
[TBL] [Abstract][Full Text] [Related]
18. Use of a Bayesian network to predict the nighttime intraocular pressure peak from daytime measurements.
Nordmann JP; Berdeaux G
Clin Ther; 2007 Aug; 29(8):1751-60; discussion 1750. PubMed ID: 17919556
[TBL] [Abstract][Full Text] [Related]
19. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
Bournias TE; Lai J
Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
[TBL] [Abstract][Full Text] [Related]
20. Intraocular pressure response to medication in a clinical setting: the Marshfield Clinic Personalized Medicine Research Project.
McCarty CA; Mukesh BN; Kitchner TE; Hubbard WC; Wilke RA; Burmester JK; Patchett RB
J Glaucoma; 2008 Aug; 17(5):372-7. PubMed ID: 18703947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
